Bold claim: a major boxing title showdown just hit a serious hurdle, and the outcome could reshape the middleweight landscape. Janibek Alimkhanuly has reportedly tested positive for a banned substance ahead of his highly anticipated unification bout with Erislandy Lara, throwing the fight into uncertainty and prompting immediate consequences.
The World Boxing Organisation (WBO) says it has received confirmation of a positive result from the Voluntary Anti-Doping Association (Vada), and an internal probe is now in progress. Alimkhanuly, who holds both the IBF and WBO titles, has been removed from the scheduled clash with Lara and has been replaced by Venezuela’s Johan Gonzalez, according to American media outlets.
Initial reports indicate the substance is meldonium, a performance-enhancing drug known to boost endurance. Meldonium has been prohibited by the World Anti-Doping Agency (WADA) since 2016. The fighter’s A sample returned an adverse finding, and Alimkhanuly has requested that the B sample be tested to confirm or contest the result.
On his social platform, X, Alimkhanuly expressed surprise at the findings and reaffirmed his support for clean sport. He noted that Vada’s first test had come back clean and stated that he has not altered his vitamins. Regarding the second test, he said he does not understand what happened and is seeking a retest.
Context: Alimkhanuly’s last ring appearance came on April 5, when he preserved his WBO and IBF belts with a fifth-round stoppage over Anauel Ngamissengue. The 32-year-old has an undefeated run of 17 professional victories since turning pro in 2016.
Erislandy Lara, the WBA champion, last fought around a year-and-a-half ago, compiling a ninth-round stoppage of Danny Garcia to secure the title. The 42-year-old veteran, a former light-middleweight champion who debuted in 2008, has 31 wins in 37 pro bouts.
Gonzalez, 34, steps in as the replacement challenger. He sports a 36-4-0 record, with his most recent result a March win over Jarrett Hurd by split decision.
This development introduces a controversial twist just days before a bout that many fans anticipated would shape the middleweight division for years to come. How the governing bodies handle the test results, the potential B-sample outcome, and the impact on the fighters’ legacies will be watched closely by promoter teams, athletes, and fans alike. What are your thoughts on this turn of events—does it change how you view the matchup, and should there be stricter pre-fight testing protocols to prevent such disruptions in the future?
